Price Alert

Cullinan Therapeutics Inc... (CGEM)

NASDAQ: CGEM · Real-Time Price · USD

6.91

-0.81 (-10.49%)

At close: Sep 04, 2025, 3:59 PM

6.94

0.43%

After-hours: Sep 04, 2025, 07:58 PM EDT

Company Description

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies.

Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617.

The company was founded by Patrick A.

Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Cullinan Therapeutics Inc.

Address: One Main Street Cambridge, Massachusetts United States
Website	https://cullinantherapeutics.com

Name	Position
Nadim Ahmed	President, Chief Executive Officer & Director
Jacquelyn L. Sumer J.D.	Chief Legal Officer, Chief Compliance Officer & Corporate Secretary
Mary Kay Fenton CPA	Chief Financial Officer
Dr. Corinne Savill Ph.D.	Chief Business Officer
Dr. Jeffrey Jones M.B.A., M.D., M.P.H.	Chief Medical Officer
Dr. Jennifer Michaelson Ph.D.	Chief Scientific Officer
Dr. Patrick A. Baeuerle Ph.D.	Co-Founder, Chief Scientific Advisor & Chairman of Scientific Advisory Board
Kevin A. Johnston	Chief Technical Operations Officer
Rose Weldon	Senior Vice President of Corporate Affairs
Steve Andre	Chief Human Resources Officer